Results 201 to 210 of about 22,844 (235)

Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models. [PDF]

open access: yesNat Commun
Ott CA   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy